00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Moderna beat Wall Street's third quarter earnings and revenue expectations
00:06and raised its full-year sales outlook, according to CNBC.
00:11The biotech company reported earnings of $0.38 per share on revenue of $1.31 billion.
00:17Analysts expected a loss of $1.25 per share and revenue of $885 million.
00:24Revenue rose 29% from a year earlier, driven by higher international COVID vaccine sales and government partnerships.
00:33Moderna now expects revenue growth of 15% to 25% in 2026, up from its previous forecast of up
00:40to 10%.
00:41CEO Stéphane Bancel credited newer products and geographic diversification for the strong quarter.
00:48Moderna shares rose about 5% in pre-market trading Friday.
00:51The stock has surged more than 700% this year amid optimism surrounding its experimental cancer vaccine with Merck.
00:59For all things money, visit Benzinga.com.
